Research Reagents

Molecular Probes for Identification or Isolation of Membrane Proteins
Background: The Nanobiology Program of the National Cancer Institute is seeking statements of capability or interest from parties interested in collaborative research to obtain pre-clinical data to be used to further develop, evaluate, or commercialize (more...)
(Full Text)

Antisera to Detect Phosphorylated Phosphoinositide-Dependent Kinase 1 (PDK-
Background: The National Institutes of Health, National Center for Complementary and Alternative Medicine, Diabetes Unit is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize phospho-specific (more...)
(Full Text)

HIV-1 Nucleocapsid-p7 Protein-Nucleic Acid Antagonists as HIV Treatment
The National Cancer Institute (NCI)-Developmental Therapeutics Program (DTP) - Screening Technologies Branch (STB, in collaboration with the NCI-Retroviral Assembly and Protein Chemistry Laboratories and the AIDS Vaccine Program), have identified several classes of lead (more...)
(Full Text)

Griffithsin, a Novel anti-HIV Protein with Potential Microbicidal, Therapeutic and/or Purification Utilities
Background: The National Cancer Institute (NCI) Molecular Targets Development Program (MTDP) seeks a Cooperative Research and Development Agreement (CRADA) collaborator to develop griffithsin (GRFT), a novel, potent anti-HIV protein isolated from an aqueous extract of (more...)
(Full Text)

AhR And Arnt Knockout Mouse Models
Background: The National Cancer Institute's Laboratory of Metabolism is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize separate AhR and Arnt knockout mouse models. Technology: The (more...)
(Full Text)

An Improved Non-Viral Gene Therapy System
Background: The National Cancer Institute's Nanobiology Program is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize a tumor-specific gene therapy agent. The technology is also (more...)
(Full Text)

High Throughput Isolation Of T Cells For The Treatment Of Metastatic Cancer
Background: The National Cancer Institute's Surgery Branch is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize high throughput T cell isolation technology. Technology: The adoptive transfer (more...)
(Full Text)

3-D Imaging and Mass Spectrometry of Mammalian Cells
Background: The National Cancer Institute's Cell Biology Laboratory is seeking statements of capability or interest from parties interested in collaborative research and/or partnership agreements to further develop and commercialize tools for three-dimensional mapping of cells (more...)
(Full Text)

Biomarkers For Birt-Hogg-Dube (BHD) Syndrome And Renal Cancer
Background: The National Cancer Institute's Urologic Oncology Branch is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize detection methods to screen a biomarker for (more...)
(Full Text)

Large Phage-Displayed Library Of Human Domain Antibodies (dAbs)
Background: The National Cancer Institute's Nanobiology Program is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize a large phage-displayed human domain antibody (dAb) library. Technology: Monoclonal antibody (more...)
(Full Text)

Transgenic Mouse Model For Development Of Cancer Therapeutics
Background: The National Cancer Institute's Medical Oncology Branch is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize the thymidylate synthase transgenic mouse model. Technology: Thymidylate synthase (more...)
(Full Text)

Novel Method To Differentiate Human Embryonic Stem Cells Into Dopaminergic Nerve Cells
Keywords: Parkinson's Disease, Neurological Diseases Background: The National Institute on Drug Abuse's Development and Plasticity Section is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize novel (more...)
(Full Text)

Novel Dopamine Receptor Ligands As Therapeutics For Central Nervous System Disorders
Background: The National Institute on Drug Abuse's Medications Discovery Research Branch is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize 4-phenylpiperazine derivatives as dopamine D3 (more...)
(Full Text)

Method for High-Throughput Microdissection and Analysis of Biological Samples
Background: The National Cancer Institute's Laboratory of Pathology is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize a method for target-activated microdissection. Technology: A variety of (more...)
(Full Text)

Novel Methods To Detect Membrane Proteins
Background: The National Institute on Aging's Laboratory of Cardiovascular Sciences is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize modules to aid the study (more...)
(Full Text)

Assay For The Detection Of Tumor Proliferation Inhibitors
Background: The National Cancer Institute's Laboratory of Metabolism is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize inhibitors of the Plk1 polo-box domain (PBD).   Technology: Polo-like (more...)
(Full Text)

Anti-Tumor AGgents That Effect Premature Chromosome Condensation
Background: The National Cancer Institute Laboratory of Molecular Pharmacology is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize lasonolide compounds as novel anti-cancer agents. Technology: Lasonolide A (more...)
(Full Text)

Virus-Free Human Placental Cell Lines To Study Genetic Functions
Background: The National Institute of Child Health and Human Development's  Section on Cellular Differentiation is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize immortalized virus-free (more...)
(Full Text)